Federal award
CONSEGNA PHARMA INC
W911SR22C0006
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $1,099,999.92
- Ceiling (potential value, not spending)
- $1,099,999.92
- Current value
- $1,099,999.92
- Gross positive obligations
- $1,099,999.92
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CONSEGNA PHARMA INC · NU7SAKDR52N8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CONSEGNA PHARMA INC · NU7SAKDR52N8
- Awarding agency
- Department of War · sub-agency 2100 · office W911SR
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN14 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W911SR22C0006
- Award type code
- D
- Actions
- 4 · Dec 10, 2021 to May 17, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 17, 2023 | FY2023 | P00003 | M | $0.00 | — |
| Aug 17, 2022 | FY2022 | P00002 | B | $297,636.48 | — |
| Apr 27, 2022 | FY2022 | P00001 | M | $0.00 | — |
| Dec 10, 2021 | FY2022 | 0 | — | $802,363.44 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.